OPTN (Option Therapeutics) Other Long Term Assets: $-0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Option Therapeutics Other Long Term Assets?

Option Therapeutics OPTN Other Long Term Assets is $-0.00 Mil as of Dec. 2025.

Option Therapeutics's other long-term assets for the quarter that ended in Dec. 2025 was $-0.00 Mil.

Option Therapeutics's quarterly other long-term assets declined from Jun. 2025 ($-0.00 Mil) to Sep. 2025 ($-0.00 Mil) but then increased from Sep. 2025 ($-0.00 Mil) to Dec. 2025 ($-0.00 Mil).

Option Therapeutics's annual other long-term assets increased from . 20 ($0.00 Mil) to Jun. 2024 ($-0.00 Mil) but then stayed the same from Jun. 2024 ($-0.00 Mil) to Jun. 2025 ($-0.00 Mil).

Option Therapeutics Other Long Term Assets Historical Data

* Premium members only.

The historical data trend for Option Therapeutics's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Option Therapeutics Other Long Term Assets Chart

Option Therapeutics Annual Data
Trend Jun24 Jun25
Other Long Term Assets
-0.00 -0.00

Option Therapeutics Quarterly Data
Jun24 Sep24 Dec24 Jun25 Sep25 Dec25
Other Long Term Assets Get a 7-Day Free Trial 0.00 0.00 -0.00 -0.00 -0.00

Option Therapeutics Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Frequently Asked Questions Learn more about Other Long Term Assets →
What does a Other Long Term Assets of $-0.00 Mil mean?
Option Therapeutics (OPTN) has a Other Long Term Assets of $-0.00 Mil as of Dec. 2025. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Option Therapeutics and its competitors.
Is Option Therapeutics' Other Long Term Assets too high?
Option Therapeutics' current Other Long Term Assets is $-0.00 Mil.
How does Option Therapeutics' Other Long Term Assets compare to ?
Option Therapeutics' Other Long Term Assets of $-0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long Term Assets for a Biotechnology company?
A good Other Long Term Assets depends on the Biotechnology industry context. However, Other Long Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long Term Assets mean?
A high Other Long Term Assets can signal that a stock is expensive relative to its fundamentals. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Option Therapeutics and its competitors. Option Therapeutics's current Other Long Term Assets is $-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Option Therapeutics stock overvalued right now?
Option Therapeutics (OPTN) has a current Other Long Term Assets of $-0.00 Mil. The current Other Long Term Assets is $-0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long Term Assets calculated?
Other Long Term Assets is calculated from a company's financial statements. For Option Therapeutics (OPTN), the current Other Long Term Assets is $-0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Option Therapeutics Business Description

Comparable Companies
Address 680 West Nye Lane, Suite 201, Carson, NV, USA, 89703
Option Therapeutics Inc is a clinical-stage company developing inventive drug therapies to treat debilitating and life-threatening liver disease through its investigational drug candidate BIV201 (continuous infusion terlipressin). BIV201 is administered as a patent-pending liquid formulation of terlipressin with patents issued, to date, in the U.S., China, Japan, Chile, and India.